AIP
ONCE

Ameritas Investment Partners’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Ameritas Investment Partners’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,928
Closed -$284K – 3065
2019
Q3 		$284K Hold
2,928
– – 0.01% 894
2019
Q2 		$300K Buy
2,928
+306
+12% +$33K 0.01% 874
2019
Q1 		$299K Hold
2,622
– – 0.01% 868
2018
Q4 		$103K Hold
2,622
– – 0.01% 1363
2018
Q3 		$143K Hold
2,622
– – 0.01% 1308
2018
Q2 		$217K Buy
2,622
+332
+14% +$25.6K 0.01% 1028
2018
Q1 		$152K Hold
2,290
– – 0.01% 1235
2017
Q4 		$118K Hold
2,290
– – 0.01% 1406
2017
Q3 		$188K Buy
2,290
+250
+12% +$19K 0.01% 1095
2017
Q2 		$122K Buy
2,040
+389
+24% +$21.7K 0.01% 1347
2017
Q1 		$88K Buy
+1,651
New +$98K ﹤0.01% 1502

Ameritas Investment Partners's ONCE Position: Q4 2019 in Review

Ameritas Investment Partners sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 2,928 shares — an estimated $284K sold.

Ameritas Investment Partners first reported a position in ONCE in Q1 2017 and held it in 11 quarters. The position peaked at $300K in Q2 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • Ameritas Investment Partners reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Ameritas Investment Partners sold 2,928 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $284K.
  • Ameritas Investment Partners first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2017 and held it in 11 quarters.
  • Ameritas Investment Partners's Spark Therapeutics, Inc. Common Stock position peaked at $300K in Q2 2019.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Ameritas Investment Partners's 13F filing for Q4 2019, filed 13 Feb 2020.